Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Neurology

Navigating Care: Managing Symptoms and Building Your Team

At a Glance

While there is no cure for FXTAS, symptoms like tremors, balance issues, and mood changes can be managed effectively with a multidisciplinary care team. Treatment involves targeted medications for motor symptoms and specialized therapies to maintain independence.

Managing FXTAS is a journey that requires a comprehensive, team-based approach. While there is currently no cure or “disease-modifying” treatment that can stop the underlying biology of FXTAS, many of the symptoms can be managed aggressively to improve your quality of life and maintain independence for as long as possible [1][2].

The Multidisciplinary Care Team

Because FXTAS affects movement, thinking, mood, and family genetics, you should ideally be supported by a team of specialists rather than just one doctor [3][4].

  • Genetic Counselor: Because FXTAS is hereditary, this specialist is critical for explaining how the FMR1 gene affects you and what the diagnosis means for your children and extended family [5].
  • Neurologist: Preferably a movement disorder specialist who understands the nuances between FXTAS, Parkinson’s, and Essential Tremor.
  • Physical Therapist (PT): Focuses on balance training, gait safety, and strength to prevent falls [4].
  • Occupational Therapist (OT): Helps you adapt daily tasks, like eating or dressing, to manage tremors [4].
  • Speech-Language Pathologist (SLP): Crucial for evaluating swallowing safety (dysphagia) and helping with speech or communication changes [6][7].
  • Psychiatrist/Psychologist: Manages the anxiety, depression, or irritability that can occur as biological symptoms of the condition [8].

Managing Motor Symptoms

Treatment for the physical symptoms of FXTAS often “borrows” medications that are successful for other conditions [2].

Tremor Management

  • Medications: Doctors may prescribe drugs like propranolol (a beta-blocker) or primidone (an anti-seizure medication) to dampen the “intention tremor” that happens when you reach for things [2][1].
  • Surgical Options & Critical Risks: For severe tremors, doctors sometimes use surgeries like Deep Brain Stimulation (DBS) or Gamma Knife Thalamotomy [9][10]. However, in patients with FXTAS, these surgeries carry significant risks. While DBS might reduce the tremor, it has been known to severely worsen ataxia (balance issues) and accelerate cognitive decline in FXTAS patients [10][9]. Because of this, surgery is considered extremely carefully, only for highly specific cases, and only after rigorous review by a multidisciplinary team.

Parkinsonism Management

If you experience stiffness or slow movement, your doctor may try carbidopa/levodopa, the standard treatment for Parkinson’s disease. While some people with FXTAS find it helpful, it often works less effectively than it does for traditional Parkinson’s patients [2][4].

Looking Toward the Future: Research

Current research is shifting from managing symptoms to finding ways to stop the disease. Scientists are exploring “disease-modifying” tools in laboratories, such as:

  • Targeting Toxic RNA: Finding ways to block or reduce the toxic mRNA that builds up in the brain [11][12].
  • Reducing Toxic Protein (FMRpolyG): Investigating compounds that prevent the production of the harmful “junk” proteins that clog cells [13][14].

Although these are mostly in early research stages, they represent the next frontier in FXTAS care [12]. Staying connected with a specialist who follows these updates can ensure you are the first to know when new clinical trials become available.

Common questions in this guide

How are tremors treated in FXTAS?
Tremors in FXTAS are typically managed using medications borrowed from other conditions, such as beta-blockers like propranolol or anti-seizure drugs like primidone. These medications help reduce the shaking that occurs when reaching for objects.
Is Deep Brain Stimulation (DBS) safe for FXTAS patients?
Deep brain stimulation carries significant risks for people with FXTAS. While it may reduce tremors, the surgery has been known to severely worsen balance issues and accelerate cognitive decline. It is only considered in highly specific cases after a rigorous team review.
Which specialists should be on my FXTAS care team?
Because FXTAS affects movement, thinking, mood, and family genetics, you need a diverse team. This ideally includes a movement disorder neurologist, genetic counselor, physical therapist, occupational therapist, speech-language pathologist, and psychiatrist.
Do Parkinson's medications help with FXTAS symptoms?
Doctors may prescribe carbidopa/levodopa, which is the standard treatment for Parkinson's disease, to help with stiffness and slow movement. However, it is often less effective for patients with FXTAS than it is for those with traditional Parkinson's.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which of my symptoms—tremor, balance, or parkinsonism—should we prioritize for treatment first?
  2. 2.Given the risks to balance and cognition, is surgical intervention like DBS truly safe for my specific presentation of FXTAS?
  3. 3.Can you refer me to a physical therapist and a speech therapist who specifically understand cerebellar ataxia and FXTAS?
  4. 4.Are there any active clinical trials for FXTAS that I might be eligible for?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Clinimetric Properties of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale.

    Hall DA, Stebbins GT, Jacquemont S, et al.

    Movement disorders clinical practice 2019; (6(2)):120-124 doi:10.1002/mdc3.12708.

    PMID: 30838310
  2. 2

    The spectrum of tremor among carriers of the FMR1 premutation with or without the fragile X-associated tremor/ataxia syndrome (FXTAS).

    Fay-Karmon T, Hassin-Baer S

    Parkinsonism & related disorders 2019; (65()):32-38 doi:10.1016/j.parkreldis.2019.05.010.

    PMID: 31126791
  3. 3

    A case of Fragile X-associated tremor/ataxia syndrome (FXTAS).

    Mishra SK, Khosa S, Trikamji B, et al.

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2019; (66()):269-270 doi:10.1016/j.jocn.2019.05.044.

    PMID: 31178302
  4. 4

    Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications.

    Cabal-Herrera AM, Tassanakijpanich N, Salcedo-Arellano MJ, Hagerman RJ

    International journal of molecular sciences 2020; (21(12)) doi:10.3390/ijms21124391.

    PMID: 32575683
  5. 5

    Prognostic dilemmas and genetic counseling for prenatally detected fragile X gene expansions.

    Finucane B, Lincoln S, Bailey L, Martin CL

    Prenatal diagnosis 2017; (37(1)):37-42 doi:10.1002/pd.4963.

    PMID: 27862088
  6. 6

    Prevalence of Speech and Swallowing Dysfunction and Intervention Among Individuals With Myasthenia Gravis.

    Gallagher TJ, Maria CS, Johns MM

    OTO open 2025; (9(1)):e70077 doi:10.1002/oto2.70077.

    PMID: 40046908
  7. 7

    Speech language pathology evaluation is associated with decreased mortality in hip fracture patients with dysphagia.

    Vennitti C, Boyapati R, Riggs K, et al.

    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie 2025; (35(1)):413 doi:10.1007/s00590-025-04533-9.

    PMID: 41042350
  8. 8

    Developmental aspects of FXAND in a man with the FMR1 premutation.

    Santos E, Emeka-Nwonovo C, Wang JY, et al.

    Molecular genetics & genomic medicine 2020; (8(2)):e1050 doi:10.1002/mgg3.1050.

    PMID: 31899609
  9. 9

    Fragile X-associated tremor/ataxia syndrome treated with multitarget deep brain stimulation.

    Okoroafor F, Beattie H, Qiang Z, Yianni J

    BMJ case reports 2024; (17(5)) doi:10.1136/bcr-2023-259452.

    PMID: 38802254
  10. 10

    Making a Difference-Positive Effect of Unilateral VIM Gamma Knife Thalamotomy in the Therapy of Tremor in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS).

    Alster P, Koziorowski DM, Za Bek M, et al.

    Frontiers in neurology 2018; (9()):512 doi:10.3389/fneur.2018.00512.

    PMID: 29997574
  11. 11

    FMRpolyG alters mitochondrial transcripts level and respiratory chain complex assembly in Fragile X associated tremor/ataxia syndrome [FXTAS].

    Gohel D, Sripada L, Prajapati P, et al.

    Biochimica et biophysica acta. Molecular basis of disease 2019; (1865(6)):1379-1388 doi:10.1016/j.bbadis.2019.02.010.

    PMID: 30771487
  12. 12

    Repurposing Nitazoxanide to target the expanded r(CGG)n repeat RNA for therapeutic intervention in fragile-X tremor/ataxia syndrome.

    Singh K, Shukla S, Kumari AP, et al.

    International journal of biological macromolecules 2025; (329(Pt 2)):147864 doi:10.1016/j.ijbiomac.2025.147864.

    PMID: 41015363
  13. 13

    Tyrosine Peptides Alleviates Multifaceted Toxicity Linked to Expanded CGG Repeats in Fragile X‑Associated Tremor/Ataxia Syndrome.

    Singh K, Shukla S, Ghosh T, et al.

    ACS pharmacology & translational science 2025; (8(6)):1536-1555 doi:10.1021/acsptsci.4c00647.

    PMID: 40534679
  14. 14

    Curcumin Regulates the r(CGG)exp RNA Hairpin Structure and Ameliorate Defects in Fragile X-Associated Tremor Ataxia Syndrome.

    Verma AK, Khan E, Mishra SK, et al.

    Frontiers in neuroscience 2020; (14()):295 doi:10.3389/fnins.2020.00295.

    PMID: 32317919

This page provides educational information on managing FXTAS symptoms. Always consult your neurologist and multidisciplinary care team before starting or stopping any medications or considering surgical interventions.

Get notified when new evidence is published on Fragile X-associated tremor/ataxia syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.